The present invention relates to microbead populations, and more particularly to a method of producing microbead populations that mimic the fluorescence intensity profile distribution of fluorescent biological cells so that they may be used as a standard for flow cytometry.
Microbeads have been used as surrogate cell standards in various biological fields for many years. This is especially true since highly uniform microbeads, in the 2-15 micron diameter range, have been first produced by John Ugelstad. As a particle surrogate, polymeric microbeads have high physical stability, as well as the ability to be labeled with the same fluorochromes and dyes as used to label biological cells. Moreover, a great deal of work has been addressed to make microbeads useful as fluorescent particle reference and quantitative standards. When labeled with such fluorochromes and dyes, these microbeads exhibit many of characteristics as labeled biological cells, as determined by instrumentation of at least one of flow cytometry. Specifically, fluorochrome labeled microbeads appear to have similar forward and side light scatter properties, as well as similar spectral and intensity fluorescent properties as biological cells.
However, the fluorescence intensity distribution profile of microbeads and biological cells labeled with the same fluorochrome can appear vastly different. For example human lymphocytes labeled with a fluorescently conjugated CD8 antibody, has a fluorescence intensity distribution, as shown in
Much effort in the manufacture of microbeads is focused on producing highly uniform physical properties, of at least one of size, volume and fluorescence intensity. Such populations are highly sort after for use as size and fluorescence standards in fields of at least one of flow cytometry and fluorescence microscopy. Normally, these methods of production ensure that fluorochromes or dyes are taken up by the microbeads in a highly uniform fashion resulting in a very tight fluorescence intensity distribution, as shown in
However, it stands to reason that, the closer the standards mimic analyte being measured, the better the instrument performance can be evaluated to measure the analyte. An example to illustrate this may be found when counting CD8 labeled lymphocytes. If a fluorescent population of microbeads with the usual tight intensity distribution is used as the count standard, the standard is only determining the ability of the instrument to detect and count events in a narrow range of the intensity scale, as shown in
The present invention solves this need by providing a method to manipulate a population of microbeads labeled with a fluorescent material or optical dye so that it mimics the fluorescent intensity distribution of a biological cell population labeled with the same fluorescent material or dye. This may be accomplished by a number of ways which include, but are not limited to at least one of: 1) mixing microbead populations of different intensities and uniformities, 2) manipulating the method of addition of the fluorescent material or 3) performing precision photo bleaching of a uniform population of microbeads.
To achieve the foregoing and other advantages, the present invention, briefly described, provides method to manipulate a population of microbeads labeled with a fluorescent material or dye so that it mimics the fluorescent intensity distribution of a biological cell population labeled with the same fluorescent material or optical dye, by mixing different uniform populations of microbeads labeled with a fluorescent material in specific proportions, the overall fluorescent intensity pattern of the mixture can result in the same intensity pattern of the a cell population of interest labeled with the same material.
The intensity profile of a labeled cell population is also mimicked by carefully adjusting the physical parameters during the dying or polymerization procedure of the microbeads. Namely, adjusting the rate of dye addition, the stirring conditions and varying concentrations of the fluorescent material during the process.
Further another method of adjusting a fluorescence intensity profile of a microbead population is accomplished using a process referred to as photo bleaching. That is, when fluorescent materials are exposed to strong light, especially wavelengths within their absorption spectra, the fluorescent molecules undergo destruction at some intrinsic rate, resulting in lower fluorescent intensity of the population as a whole. However, if different portions of the uniform population of microbeads are photobleached in a precise and predetermined manner at specific rates, the resulting intensity profile of the microbead population can be made to mimic the intensity profile of the labeled biological cells. This process is referred to as precision photo bleaching.
Numerous objects, features and advantages of the present embodiment of the invention will be readily apparent to those of ordinary skill in the art upon a reading of the following detailed description of presently preferred, but nonetheless illustrative, embodiments of the invention when taken in conjunction with the accompanying drawings. In this respect, it is to be understood that the embodiment of the invention is not limited in its application to the details of construction and to the arrangements of the components set forth in the following description or illustrated in the drawings. The invention is capable of other embodiments and of being practiced and carried out in various ways. Also, it is to be understood that the phraseology and terminology employed herein are for the purpose of descriptions and should not be regarded as limiting.
As such, those skilled in the art will appreciate that the conception, upon which this disclosure is based, may readily be utilized as a basis for the designing of other structures, methods and systems for carrying out the several purposes of the present invention. It is important, therefore, that the claims be regarded as including such equivalent constructions insofar as they do not depart from the spirit and scope of the present embodiment of the invention.
This specification and the accompanying figures disclose the preferred embodiment as example of the invention. The drawings illustrated in the figures are not to scale and are only intended to serve as illustrating examples of the invention. The invention is not intended to be limited to the embodiment illustrated. Numerous modifications, changes, variations, substitutions and equivalents will be apparent to those skilled in the art without departing from the spirit and scope of the present invention.
Referring now to
In general, the microbeads are uniformly spread over a given area. This may be done by filling a shallow flat-bottomed container and allowing the microbeads to settle uniformly onto the bottom of the container. An optical density gradient is placed over these microbeads and a light source of optimal wavelengths is directed through density gradient onto the uniform layer of microbead. The intensity and length of time the light is directed onto the microbeads controls the overall fluorescence intensity of the population, however, the intensity profile within the microbead population will retain an intensity profile across the illuminated area inversely proportional to the density gradient covering the microbeads.
More specifically, the microbead surrogate cell standard is produced from a profile of an actual fluorescently labeled biological cell population by obtaining a list mode file from the cell population of interest with a flow cytometer. The channel number and correlated event data from the list mode file is then transferred to a spreadsheet indicating the number of events represented in each channel of the intensity scale as shown in
Mix together proportions of a series fluorescence microbead populations labeled with phycoerythrin (PE) of increasingly fluorescence intensity by a factor of 0.3 decades of the same size that have wide intensity distributions, e.g., >25%. Suspend this mixture in a diluent containing 0.1% Tween 20 and run this mixture in a flow cytometer, gate on the singlet to obtain a FL2 histogram. The resulting histogram mimics the low intensity population of CD8 labeled PE lymphocytes.
After swelling polymethyl methacrylate microbeads with 100% methanol, propidum iodide (PI) dissolved in methanol was introduced at the top of the microbead suspension without stirring. The PI was allowed to diffused down through the suspension while the microbeads were settling to the bottom. After 30 minutes, the methanol was decanted from the microbeads and they were re-suspended in PBS containing 0.1% Tween 20. The fluorescence intensity distribution of the microbead population was found to have a wide distribution skewed to the left, >60% CV.
A highly uniform population of fluorescein-labeled microbeads was allowed to settle over an area so that the resulting microbeads formed a uniformly thick layer. Most of the suspension solution was removed so that the microbeads were covered by only a few millimeters of solution. An optical density gradient produced by applying the algorithm to a list mode histogram file from gated CD8 FITC labeled lymphocytes. This gradient was placed 5 mm above the uniform layer of microbeads and a 50 w high intensity lamp was directed onto the gradient for 2 hours so that the layer of microbeads was exposed to the resulting gradient light levels. The microbeads were then re-suspended and washed in PBS containing 0.1% Tween 20. The resulting fluorescent intensity histogram of the precision photobleached microbeads mimicked the gated CD8 FITC labeled lymphocytes
While a preferred embodiment of the invention has been described in detail, it should be apparent that modifications and variations thereto are possible, all of which fall within the true spirit and scope of the invention.
With respect to the above description then, it is to be realized that the optimum dimensional relationships for the parts of the invention, to include variations in size, materials, shape, form, function and manner of operation, assembly and use, are deemed readily apparent and obvious to one skilled in the art, and all equivalent relationships to those illustrated in the drawings and described in the specification are intended to be encompassed by the present embodiment of the invention.
Therefore, the foregoing is considered as illustrative only of the principles of the embodiment of the invention. Further, since numerous modifications and changes will readily occur to those skilled in the art, it is not desired to limit the embodiment of the invention to the exact construction and operation shown and described, and accordingly, all suitable modifications and equivalents may be resorted to, falling within the scope of the embodiment of the invention.
Number | Name | Date | Kind |
---|---|---|---|
4698262 | Schwartz et al. | Oct 1987 | A |
4699826 | Schwartz et al. | Oct 1987 | A |
4699828 | Schwartz et al. | Oct 1987 | A |
4714682 | Schwartz | Dec 1987 | A |
4774189 | Schwartz | Sep 1988 | A |
4828984 | Schwartz | May 1989 | A |
4857451 | Schwartz | Aug 1989 | A |
4868126 | Schwartz | Sep 1989 | A |
4918004 | Schwartz | Apr 1990 | A |
5073498 | Schwartz et al. | Dec 1991 | A |
5380190 | Kumagai | Jan 1995 | A |
5380663 | Schwartz et al. | Jan 1995 | A |
20030055233 | Krull | Mar 2003 | A1 |
20070236796 | Putnam et al. | Oct 2007 | A1 |
Number | Date | Country | |
---|---|---|---|
20100203642 A1 | Aug 2010 | US |